在早期癌症检测中"成功"的欺骗性措施
1Melbourne Dental School, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Carlton, VIC 3053, Australia.
Current oncology (Toronto, Ont.)
|September 27, 2024
概括
评估癌症早期检测测试需要谨慎的成功标准. 通常使用的指标可能会误导,可能导致过度诊断和过度治疗,扭曲真正的健康结果改善.
科学领域:
- 在瘤学瘤学.
- 预防医学 预防医学
- 生物统计学 生物统计学
背景情况:
- 早期发现癌症对于降低死亡率至关重要.
- 目前的查计划旨在早期诊断.
- 需要有意义的成功标准来反映真正的健康益处.
研究的目的:
- 讨论目前用于评估早期癌症检测测试的指标的局限性.
- 为了强调常见的成功标准是如何欺骗性的.
- 强调需要对癌症查有效性的准确评估.
主要方法:
- 分析癌症查中常用的指标.
- 欺骗性统计措施的说明性例子.
- 讨论生存统计和相对指标中的偏差.
主要成果:
- 早期检测可能会导致病期下降,而不会减少晚期疾病,导致过度诊断.
- 存活率统计数据 (例如,癌症特异性存活率) 可能会由于领先时间偏差而导致误导.
- 相对措施 (比例,比率) 可以扭曲查的感知好处.
结论:
- 癌症早期检测成功的常用指标可能是欺骗性的.
- 过度诊断和过度治疗是错误指标的潜在后果.
- 对癌症检测方法的准确评估对于患者护理至关重要.
相关概念视频
01:21Cancer Survival Analysis
331
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
331
01:24Kaplan-Meier Approach
107
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
107